About Immutopics
Immutopics is a company based in San Clemente (United States) founded in 1989 was acquired by Quidel in March 2016. Immutopics operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
- Headquarter San Clemente, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Quidel
(Mar 18, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Immutopics
Detailed funding history for Immutopics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Immutopics
Immutopics has secured backing from 1 investor. Prominent investors backing the company include QuidelOrtho.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
QuidelOrtho is engaged in providing diagnostic testing solutions globally.
|
Locked | Locked | Locked |
Investor details for Immutopics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Immutopics
Investment portfolio details for Immutopics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Immutopics
Detailed financials for Immutopics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Immutopics Comparisons
Peer comparison for Immutopics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Immutopics
Immutopics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Develops tools and products for research and clinical application
|
|
| Locked | Locked | Locked |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
Detailed competitors of Immutopics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Immutopics
Complete news archive for Immutopics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Immutopics
Immutopics was founded in 1989.
Immutopics is headquartered in San Clemente, United States. It is registered at San Clemente, California, United States.
Immutopics develops, manufactures and markets immunoassays for assessing bone health to the research and scientific communities. Its product line includes ELISA kit for the determination of Human fibroblast Growth Factor-23 levels in plasma or cell culture media, ELISA kit for quantitative determination of Human Intact FGF-23 levels, ELISA kit for Human Bioactive Intact PTH levels, ELISA kit for quantitative determination of Human parathyroid hormone 1-34 levels, and ELISA kit for detection of Anti-Human PTH (1-34) antibodies in Serum, Plasma or Cell culture media. The company got acquired by Diagnostic Hybrids, Inc., a wholly owned subsidiary of Quidel Corporation, on March 18, 2016.
Immutopics's top competitors include Abcam, Sino Biological and Meridian Bioscience.
Immutopics has 1 investor. Key investors include QuidelOrtho.